Gain Therapeutics, Inc. Stock Forecast
Gain Therapeutics, Inc. stock price down 1.35% on Thursday
(Updated on May 02, 2024)
The Gain Therapeutics, Inc. stock price fell by -1.35% on the last day (Thursday, 2nd May 2024) from $2.97 to $2.93. During the last trading day the stock fluctuated 6.59% from a day low at $2.87 to a day high of $3.06. The price has fallen in 7 of the last 10 days and is down by -6.98% for this period. Volume has increased on the last day by 63 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 121 thousand shares were bought and sold for approximately $355.16 thousand.
The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.86 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -37.77% during the next 3 months and, with a 90% probability hold a price between $1.78 and $2.14 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
GANX Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, April 30, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Gain Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.02 and $3.54. A break-up above any of these levels will issue buy signals. Gain Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Gain Therapeutics, Inc. stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.189 between high and low, or 6.59%. For the last week, the stock has had daily average volatility of 5.97%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (GANX) For The Upcoming Trading Day Of Friday 3rd
For the upcoming trading day on Friday, 3rd we expect Gain Therapeutics, Inc. to open at $2.95, and during the day (based on 14 day Average True Range), to move between $2.67 and $3.19, which gives a possible trading interval of +/-$0.262 (+/-8.95%) up or down from last closing price. If Gain Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 17.90% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $3.15, some $0.220 (7.51%) from the current price of $2.93, our system finds the risk reward not very attractive.
Earnings coming up
Gain Therapeutics, Inc. will release earnings BMO on Friday, May 10, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.300. We will update the financials statements for Gain Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.18% in the first trading day after earnings release.
Is Gain Therapeutics, Inc. stock A Buy?
Gain Therapeutics, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -4.670 Sell Candidate Unchanged
Predicted Opening Price for Gain Therapeutics, Inc. of Friday, May 3, 2024
| Fair opening price May 3, 2024 | Current price |
|---|---|
| $2.95 ( 0.785%) | $2.93 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for GANX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.14 | 7.24 % | |
| R2 | 3.07 | 4.77 % | ||
| R1 | 3.03 | 3.25 % | ||
| Current price: | 2.93 | |||
| Support | S1 | 2.88 | -1.68 % | |
| S2 | 2.84 | -3.20 % | ||
| S3 | 2.76 | -5.67 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.65 | 24.57 % | |
| R2 | 3.58 | 22.18 % | ||
| R1 | 3.15 | 7.51 % | ||
| Current price | 2.93 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Gain Therapeutics, Inc. Stock.
